QuidelOrtho

QDELNasdaq United States Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$728.271 M

$10.62 -4.24%

Close of 18 Sept 2026

Revenue

$2.73B

#979 by revenue

Earnings

-$1.13B

Loss-making

Shares outstanding

68,575,427

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →

#7Achieve Life SciencesACHV$821.2M
#8Anbio BiotechnologyNNNN$755.4M
#9QuidelOrthoQDEL$728.3M
#10Alpha TeknovaTKNO$418.2M
#11Myriad GeneticsMYGN$372.1M

What if QuidelOrtho were worth as much as…

Open the what-if tool →

Gold $30.4T

$443,124.60

Per share 41,725× higher

Bitcoin $1.64T

$23,857.35

Per share 2,246× higher

Nvidia $5.36T

$78,114.09

Per share 7,355× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for QuidelOrtho are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.